Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
6
×
life sciences
national blog main
new york blog main
6
×
biotech
national top stories
san diego blog main
startups
boston blog main
new york top stories
san diego top stories
san francisco blog main
amgen
boston top stories
cancer
cancer diagnostics
clinical trials
fda
merck
novartis
raleigh-durham blog main
san diego
san francisco top stories
seattle blog main
seattle top stories
the medicines company
vc
wisconsin blog main
wisconsin top stories
10x genomics
abbvie
achaogen
adams street partners
adverum biotechnologies
albert bourla
alirocumab
alnylam pharmaceuticals
alzheimer's disease
amicus therapeutics
antibiotics
What
company
6
×
deal
drug
medicines
acquire
acquisitions
add
adding
advance
agreed
aims
albert
bacteria
based
biggest
billion
bio
biology
biopharma
bourla
brings
business
cash
ceo
cholesterol
compound
crispr
cytokine
decisions
deerfield
diagnostic
diagnostics
disease
domestic
drugs
enhanced
exited
expand
fda
fighting
Language
unset
unknown
Current search:
company
×
deals
×
" new york blog main "
×
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Shine Raises $30M, Could Add $150M More After Inking Deerfield Deal
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections